"plants goodwin"

NATERA Plant Based Foods Featured at DirectFood.store

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) is pleased to announce that NATERA Plant-Based Foods is now available through DirectFood.store

DirectFood.store is a British Columbia based food delivery company offering a wide variety of local food throughout the Greater Vancouver Region. The company offers a first-of-its-kind sustainable solution for grocery shopping with a zero-waste system. DirectFood.store does not have any warehouses with all food being picked up directly from the farms or vendors in the morning and delivered to customers later that day.

DirectFood.store CEO Mr. Colin Schmidt states, "We recognized that the COVID outbreaks, coupled with the uncertainty of supply chains created the need for a more resilient way to get food to market and this is where DirectFood.store excels. We are seeing more and more demand for plant-based products, and the Naturally Splendid brand of NATERA Plant Based entrees is an excellent fit for our rapidly growing customer base. We look forward to growing this opportunity with Naturally Splendid and NATERATM."

Naturally Splendid CEO Mr. J. Craig Goodwin states, "Teaming up with DirectFood.store provides an easy, affordable way to deliver our plant-based entrees to over 2.8 million people who live in the lower mainland. This is one more way to get our products to consumers as the trend of consumers looking for convenience when purchasing food continues to grow. This consumer buying trend accelerated during the initial COVID lockdown periods and we believe consumers will continue to use food delivery services, especially when quality and service are at the forefront, as it is with DirectFood.store. DirectFood.store is all about ensuring their customers receive high-quality foods and NATERA is excited to provide our delicious plant-based entrees to their valued clients. We are looking forward to working with DirectFood.store in meeting their customers' needs and tastes".

About Naturally Splendid Enterprises Ltd.

Founded in 2010, NSE operates a food manufacturing facility just outside Vancouver, BC in Canada. The Company has established numerous healthy, functional foods under recognized brands such as Natera Sport™, Natera Hemp Foods, CHII, Elevate Me™ and Woods Wild Bar™, and most recently Natera Plant Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment. The Company has a myriad of new products and line extensions under development that are approaching launch. NSE, through its joint venture Plasm Pharmaceutical, has been approved for conducting a phase 2 clinical trial approved by Health Canada for treatment of COVID-19. NSE has also developed proprietary technologies for the extraction of high-demand, healthy omega 3 and 6 oils from hemp.

NSE contract manufacturers for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many healthy food companies, private labeling a wide variety of nutritional food products destined for global healthy food markets.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-465-0548 (ext. 105)

About DirectFood.store

Founded in the spring of 2020 as a division of Wisebox Solutions Inc., and as part of the i-Open Group of companies, DirectFood.store (DFS) operates throughout the lower mainland of BC, Canada, serving from Vancouver to Chilliwack.

DFS provides consumers, restaurants, and charities with free delivery for orders placed directly from local farms and vendors. Separate invoices and card charges reinforce that they are buying direct, even though they have the convenience of shopping in a shared regional marketplace with all their food arriving together. For local farms, DFS's unique many-to-many delivery model and logistics software shorten the supply chain to enable just-in-time harvesting. As a result, the food is fresher and healthier while limiting food waste and environmental impact.

On Behalf of the Board of Directors

Mr. J. Craig Goodwin CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP - TSX Venture; NSPDF - OTCQB; 50N - Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
E-mail : info@naturallysplendid.com
Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions, and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: Naturally Splendid Enterprises Ltd.



View source version on accesswire.com:
https://www.accesswire.com/677786/NATERA-Plant-Based-Foods-Featured-at-DirectFoodstore

News Provided by ACCESSWIRE via QuoteMedia

NSP:CA
The Conversation (0)
Naturally Splendid Reports Third Quarter Results for 2022 and Company Update

Naturally Splendid Reports Third Quarter Results for 2022 and Company Update

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) announces its unaudited financial results for the nine months ended September 30, 2022. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards

Naturally Splendid CEO Mr. Craig Goodwin states, "As we continue to focus our efforts and resources on PlanteinTM Plant-Based Foods and our ten (10) year exclusive manufacturing and distribution agreement with Flexitarian Foods PTY Ltd., there have been many positives as well as a number of challenges. The positives include our recent launch into retail, and the return to trade shows where are products have been getting exceptional reviews, as well as our expanding relations with our national distributors. However, the Company has experienced significant challenges as well, the most notable being the continued delay of customized manufacturing lines being assembled in Shanghai, China. The delay to date has been due to a combination of shortage of computer chips, combined with on-going Covid challenges and subsequent quarantining in Shanghai".

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Naturally Splendid Management Update

Naturally Splendid Management Update

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) announces that Mr. George Ragogna will be stepping down as CFO and a Member of the Board of Directors effective immediately

Mr. Ragogna will remain with the Company as an Independent Consultant, focusing his efforts on logistics and our inventory management control system. Mr. Bryan Carson, current Executive VP and Company Co-founder, will step in as interim CFO.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Naturally Splendid Presents at Grocery Innovations Canada Trade Show in Toronto

Naturally Splendid Presents at Grocery Innovations Canada Trade Show in Toronto

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) is pleased to announce the Company presented the PlanteinTM line of plant-based entrees at the Grocery Innovations Canada trade show on October 25 and October 26, 2022, at the Toronto Congress Centre

Grocery Innovations Canada, is one of Canada's premier grocery trade show events, bringing together manufacturers and retailers from not only Eastern Canada, but in fact from all across the country. Naturally Splendid featured the PlanteinTM line of plant-based products to retailers and distributors from across the country.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Vegan Supply to Distribute Plantein Through Foodservice Network & Sell in Retail Store

Vegan Supply to Distribute Plantein Through Foodservice Network & Sell in Retail Store

VANCOUVER, BC / ACCESSWIRE/ September 6, 2022 / Naturally Splendid Enterprises Ltd.("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC Pink:NSPDF) is pleased to announce that Vegan Supply will carry a selection of PlanteinTM products for its retail and foodservice customers.

Vegan Supply, a Vancouver based company with both retail and foodservice distribution, began business in 2015 as the world's largest e-commerce marketplace exclusively providing their retail customers and foodservice clients with high-quality vegan products. Vegan Supply is listing five (5) PlanteinTM plant-based entrees: Nuggets, Schnitzel, Crumbed Tenders, Sweet Chili Tenders, and Crispy Burgers. The PlanteinTM line of products will be available through Vegan Supply's retail store in Vancouver, BC, their e-commerce platform, and marketed to their foodservice distribution network.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
CORRECTION: Naturally Splendid Reports Second Quarter Results for 2022

CORRECTION: Naturally Splendid Reports Second Quarter Results for 2022

This release acts as a correction for the release posted on 8/29/2022 at 10:30 PM EDT from Naturally Splendid Enterprises Ltd. announcing its second quarter results for 2022 due to an error in comments stated

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) announces its unaudited financial results for the six months ended June 30, 2022. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 NASDAQ Biotech Stocks of 2024

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in the first half of 2024 in response to looming interest rate cuts, breakthrough innovations and increased deals in the space.

After dropping to a low of 3,637.05 in October 2023, the index climbed to start 2024 at 4,457.02. It did hit a bump in the road early in Q2 when it plunged to 4,056.3 in April, but it quickly recovered and has since tracked even higher, reaching 4,634.21 on June 24. But while the current economic environment means the biotech sector may have a complex road ahead, robust growth could be in store in the future.

According to a recent report from Precedence Research, the global biotech market is expected to grow at a compound annual growth rate of 11.8 percent from now to 2033, reaching a valuation of US$4.25 trillion.

Keep reading...Show less
Radiopharm Theranostics

First Patient Dosed with PD-L1 Nanobody in Phase 1 Therapeutic Non-Small Cell Lung Cancer Trial

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce the therapeutic dosing of the first patient in its Phase 1 clinical trial of RAD 204, a proprietary nanobody which targets Programmed death-ligand 1 (PD-L1)-positive expression in Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer.

Keep reading...Show less
Test tubes.

Can AI Help Detect Cancer? Data Analysis Could Open Up Possibilities for Healthcare Industry

Artificial intelligence (AI) has emerged as a valuable tool for solving complex societal issues, and although it's a new industry, its impact is already being felt in key areas of the life science sector.

AI models in healthcare are quickly advancing beyond basic tasks like medical transcription and administrative streamlining; many systems can now effectively analyze extensive genetic data.

By harnessing AI models' ability to identify patterns and make predictions, medical professionals can institute more effective, personalized treatments and develop precision tests to catch diseases earlier.

Keep reading...Show less
Biotech therapy capsule containing DNA strand surrounded by cells.

Top 3 Canadian Biotech Stocks of 2024

Biotech is a dynamic industry that is driving scientific advancements and innovation in healthcare.

According to Grandview Research, the global biotech market was worth US$1.55 trillion in 2023, and the firm expects it to grow at a CAGR of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion.

In Canada, the biotech industry is home to companies pursuing cutting-edge therapies and medical technologies, and the Investing News Network has identified the top three biotech stocks based on their year-on-year gains.

Keep reading...Show less
Radiopharm Theranostics

Investor Webinar – 3pm AEST Tuesday 2 July

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that CEO and Managing Director Riccardo Canevari and Executive Chairman Paul Hopper will conduct an investor webinar to provide an update following announcement of the Company’s $70 million capital raising.

When: 3pm AEST, Tuesday 2 July 2024

Keep reading...Show less
Researcher in medical lab looking at sample with microscope.

Oncology Stocks: 8 Biggest NASDAQ Companies in 2024

The wide-ranging oncology market covers every area of cancer care, from diagnosis to treatment.

Coming in only after cardiovascular disease, cancer is the second leading cause of death worldwide; unsurprisingly, oncology is one of the biggest sectors in the life science space. With that in mind, biotechnology and pharmaceutical companies alike are working to develop best-in-class therapeutics for the treatment of various cancers, including lung, breast and prostate cancer.

At this point, their work is far from finished — Fortune Business Insights projects that the global oncology market will increase at a compound annual growth rate of 11.3 percent to reach US$518.25 billion in 2032.

As the global oncology market grows, investors who want exposure to companies working to treat cancer should consider taking a look at biotech and pharma companies with a focus on oncology drugs and testing.

Keep reading...Show less

Latest Press Releases

Related News

×